Envoy Medical Files 8-K for Material Agreement

Ticker: COCHW · Form: 8-K · Filed: Jan 21, 2025 · CIK: 1840877

Sentiment: neutral

Topics: material-agreement, 8-k, company-update

TL;DR

Envoy Medical signed a new material agreement on Jan 17, 2025. 8-K filed Jan 21.

AI Summary

Envoy Medical, Inc. filed an 8-K on January 21, 2025, reporting a material definitive agreement entered into on January 17, 2025. The filing also includes financial statements and exhibits. Envoy Medical, Inc. is in the business of orthopedic, prosthetic & surgical appliances & supplies.

Why It Matters

This filing indicates a significant new agreement for Envoy Medical, Inc., which could impact its business operations and financial standing. Investors should monitor for details on the nature of this agreement.

Risk Assessment

Risk Level: medium — The filing reports a material definitive agreement, which could represent a significant change or event for the company, warranting closer investor attention.

Key Numbers

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Envoy Medical, Inc. on January 17, 2025?

The filing does not specify the details of the material definitive agreement, only that one was entered into on January 17, 2025, and reported via an 8-K filed on January 21, 2025.

When was Envoy Medical, Inc. incorporated and in which jurisdiction?

Envoy Medical, Inc. was incorporated in Delaware.

What is Envoy Medical, Inc.'s Standard Industrial Classification (SIC) code and industry?

Envoy Medical, Inc.'s SIC code is 3842, which corresponds to Orthopedic, Prosthetic & Surgical Appliances & Supplies.

What was Envoy Medical, Inc.'s former company name?

Envoy Medical, Inc.'s former company name was Anzu Special Acquisition Corp I.

What is the business address and phone number for Envoy Medical, Inc.?

The business address for Envoy Medical, Inc. is 4875 White Bear Parkway, White Bear Lake, MN 55110, and the business phone number is 651-361-8000.

Filing Stats: 1,084 words · 4 min read · ~4 pages · Grade level 11.5 · Accepted 2025-01-17 18:20:20

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits 5.1 Legal Opinion of Fredrikson & Byron, P.A. 10.1 At The Market Offering Agreement dated as of January 17, 2025, between Envoy Medical, Inc and Roth Capital Partners, LLC 23.1 Consent of Fredrikson & Byron P.A. (included in Exhibit 5.1) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ENVOY MEDICAL, INC. January 17, 2025 By: /s/ David R. Wells David R. Wells Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing